Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Incannex Healthcare
(NASDAQ:IXHL)
Intraday
$2.25
-0.05
[-2.17%]
After-Hours
$2.25
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.25
-0.05
[-2.17%]
At close: Apr 25
$2.25
0
[0.00%]
PreMarket: 4:07PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Incannex Healthcare Stock (NASDAQ:IXHL)
Incannex Healthcare Stock (NASDAQ: IXHL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
-
Apr 17, 2024, 8:42AM
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
-
Mar 29, 2024, 12:43PM
Friday, March 22, 2024
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
Abbey Higginbotham
-
Mar 22, 2024, 11:05AM
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
-
Mar 20, 2024, 2:49PM
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psilocybin Research Funding Bill To Governor' - Marijuana Moment
Benzinga Newsdesk
-
Mar 14, 2024, 12:42PM
Tuesday, March 05, 2024
Incannex Healthcare Tapped Treasurer and Controller Joseph Swan to Additional Role of CFO, Effective February 29 After Madhukar Bhalla Decided to Retire
Benzinga Newsdesk
-
Mar 5, 2024, 6:21AM
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
-
Mar 4, 2024, 1:48PM
Wednesday, February 28, 2024
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
Lara Goldstein
-
Feb 28, 2024, 2:33PM
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 28, 2024, 2:02PM
What's Going On With Incannex Stock?
Erica Kollmann
-
Feb 28, 2024, 11:58AM
Incannex Healthcare Shares Resume Trade
Benzinga Newsdesk
-
Feb 28, 2024, 9:44AM
Incannex Healthcare Shares Halted On Circuit Breaker To The Downside, Stock Now Up 72.8%
Benzinga Newsdesk
-
Feb 28, 2024, 9:40AM
Incannex shares are trading higher after the company announced its Psi-GAD1 trial met its primary endpoint.
Benzinga Newsdesk
-
Feb 28, 2024, 9:27AM
Market-Moving News for February 28th
Benzinga Newsdesk
-
Feb 28, 2024, 8:33AM
Incannex Announces Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
Benzinga Newsdesk
-
Feb 28, 2024, 7:34AM
Wednesday, February 21, 2024
Incannex Healthcare Shares Resume Trade
Benzinga Newsdesk
-
Feb 21, 2024, 12:09PM
Incannex Healthcare Shares Halted On Circuit Breaker To The Upside, Stock Now Up 62.3%
Benzinga Newsdesk
-
Feb 21, 2024, 12:04PM
Friday, February 16, 2024
Incannex Said It Completes Successful Pre-IND Meeting With FDA For CannQuit-N; A Novel Solution For Tobacco Smoking Cessation
Benzinga Newsdesk
-
Feb 16, 2024, 7:39AM
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
-
Feb 15, 2024, 10:55AM
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
-
Feb 15, 2024, 8:36AM
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
-
Jan 27, 2024, 10:00AM
Thursday, January 25, 2024
Podcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiers
Lara Goldstein
-
Jan 25, 2024, 1:44PM
Wednesday, January 24, 2024
Incannex Commences Dosing In Phase 2 Clinical Trial Assessing IHL-675A In Patients With Rheumatoid Arthritis
Benzinga Newsdesk
-
Jan 24, 2024, 4:29PM
Thursday, January 18, 2024
Incannex Completes Dosing And Therapy In Phase 2 "PsiGAD" Clinical Trial Assessing Psilocybin-Assisted Psychotherapy for Generalized Anxiety Disorder
Benzinga Newsdesk
-
Jan 18, 2024, 8:24AM
Wednesday, January 17, 2024
Incannex Received IRB Approval For RePOSA Phase 2/3 Clinical Trial Protocol To Assess IHL-42X Drug In Patients With Obstructive Sleep Apnea
Charles Gross
-
Jan 17, 2024, 6:12AM
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
-
Jan 12, 2024, 4:55PM
Monday, January 08, 2024
Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
Lara Goldstein
-
Jan 8, 2024, 2:33PM
Friday, December 29, 2023
Global Mofy Metaverse Reports Follow-on Offering, Joins Lyft, Coinbase Global And Other Big Stocks Moving Lower On Friday
Avi Kapoor
-
Dec 29, 2023, 10:45AM
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
-
Dec 27, 2023, 10:09AM
Friday, December 22, 2023
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
Lara Goldstein
-
Dec 22, 2023, 6:03PM
Monday, December 18, 2023
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Lara Goldstein
-
Dec 18, 2023, 12:21PM
Tuesday, December 12, 2023
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Dec 12, 2023, 1:22PM
Monday, December 11, 2023
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
Lara Goldstein
-
Dec 11, 2023, 10:43AM
Wednesday, December 06, 2023
Incannex Healthcare shares are trading lower. The company provided an update on IHL-42X Drug Candidate in Phase 2/3 clinical trial in obstructive sleep apnea.
Benzinga Newsdesk
-
Dec 6, 2023, 10:19AM
Incannex Says Results Of Proof-Of-Concept Study Confirmed Hypothesis That Combination Of Dronabinol And Acetazolamide Is Effective At Treating Obstructive Sleep Apnea
Benzinga Newsdesk
-
Dec 6, 2023, 7:39AM
Incannex Healthcare Provides Update On IHL-42X Drug Candidate In Phase 2/3 Clinical Trial In Obstructive Sleep Apnea
Benzinga Newsdesk
-
Dec 6, 2023, 7:36AM
Box Reports Weak Q3 Results, Joins Yext, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
-
Dec 6, 2023, 5:35AM
Tuesday, December 05, 2023
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Lara Goldstein
-
Dec 5, 2023, 10:12AM
Merit Medical Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
-
Dec 5, 2023, 5:21AM
Friday, December 01, 2023
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Dec 1, 2023, 12:04PM
Why UiPath Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Dec 1, 2023, 8:30AM
Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Lisa Levin
-
Dec 1, 2023, 5:15AM
Thursday, November 30, 2023
Incannex Healthcare Shares Resume Trade
Benzinga Newsdesk
-
Nov 30, 2023, 9:01AM
Friday, November 24, 2023
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
Lara Goldstein
-
Nov 24, 2023, 9:44AM
Sunday, November 12, 2023
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
Lara Goldstein
-
Nov 12, 2023, 8:39PM
Monday, November 06, 2023
Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
Lara Goldstein
-
Nov 6, 2023, 7:02PM
Sunday, October 29, 2023
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoir And More
Lara Goldstein
-
Oct 29, 2023, 10:48PM
Sunday, October 22, 2023
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Lara Goldstein
-
Oct 22, 2023, 3:18PM
Monday, October 16, 2023
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Lara Goldstein
-
Oct 16, 2023, 3:57PM
Friday, October 06, 2023
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Lara Goldstein
-
Oct 6, 2023, 5:07PM
Show more